Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled Therapeutic Reduced Airway Inflammation

Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced the results of a clinical study showing that an iCALM™ attenuated allergen-induced bronchitis in susceptible asthmatic patients.

Pulmatrix Announces Presentations at ATS 2012 International Conference

Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that six posters on its iCALM™ and iSPERSE™ inhaled drug platforms ha

Retail Health Clinics grow In Popularity

Some view them simply as a doctor office visit without the long wait. Some physicians contend the public may not understand the truly narrow scope of the services they offer. They may also be seen as a small island of opportunity for physician assistants